P

$PIPR

3 articles found
0 positive
0 negative
3 neutral
The Motley FoolThe Motley Fool··Eric Volkman

Palo Alto Networks Surges on AI Optimism and Valuation Reset

$PANW rallies 4.35% as analysts affirm AI positioning. Goldman Sachs flags oversold legacy tech; Piper Sandler maintains overweight rating with $265 target.
GSGSpAGSpCGSpDPANW+1AI disruptioncybersecurity
The Motley FoolThe Motley Fool··Keith Noonan

e.l.f. Beauty Stock Rebounds 5.3% in April After Iran Crisis-Driven 34.2% March Collapse

e.l.f. Beauty stock fell 34.2% in March due to Iran-related shipping disruptions raising petrochemical costs, then rebounded 5.3% in April following ceasefire announcements.
ELFDBDGPDGZDZZ+1stock declineoil prices
GlobeNewswire Inc.GlobeNewswire Inc.··Okyo Pharma Limited

OKYO Pharma Prices $20M Share Offering to Fund Clinical Development

OKYO Pharma prices $20M share offering to fund clinical development of urcosimod for neuropathic corneal pain treatment, advancing Phase 2b/3 trial.
OKYOPIPRclinical developmentpublic offering